PCOS (Polycystic Ovarian Syndrome) Patients
Launched by THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY · Jun 18, 2019
Trial Information
Current as of June 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the health effects of Polycystic Ovarian Syndrome (PCOS) on women both in the short term and over a longer period. PCOS is a condition that affects how a woman's ovaries work and can lead to various health issues. The trial is being conducted at the Reproductive Medical Center of the First Affiliated Hospital of Zhengzhou University in China and is currently looking for participants.
To be eligible for this study, women must have been diagnosed with PCOS based on specific criteria known as the Rotterdam criteria. There are no exclusions listed, which means they are open to a wide range of participants. If you choose to join this trial, you can expect to be part of a group that helps researchers understand more about PCOS and its impacts on health. Your participation might contribute to better treatments and support for others with this condition in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • PCOS patients diagnosed with The Rotterdam diagnostic criteria.
- Exclusion Criteria:
- • -
About The First Affiliated Hospital Of Zhengzhou University
The First Affiliated Hospital of Zhengzhou University is a leading medical institution dedicated to advancing healthcare through innovative clinical research. As a prominent teaching hospital, it combines cutting-edge medical practices with a commitment to patient-centered care. The hospital is recognized for its comprehensive array of specialties and its collaborative approach to research, fostering partnerships with academic and healthcare organizations. By engaging in rigorous clinical trials, the hospital aims to contribute to the development of new therapies and improve treatment outcomes, ultimately enhancing the quality of care for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zhengzhou, Henan, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials